Interestingly, steady increases in TREC levels in both CD4+ and CD8+ T cells were observed in UCBT patients receiving immunosuppression without active GVHD, suggesting that GVHD prophylaxis with immunosuppression alone does not necessarily cease thymopoiesis [44]. The gene discussed is CD8A; the disease is graft versus host disease.